Tumor antigen 125, abbreviated CA-125, is a glycoprotein used as a tumour marker for ovarian cancer.
271.23
–
+
Delivery / installation will take place shortly after order confirmation
Cancer Antigen 19-9 (CLIA) CA 19-9 60 Tests,incl. 2 calibrators
271.23
–
+
Delivery / installation will take place shortly after order confirmation
30+ years of experience
and end-to-end service from a single source – from installation to maintenance, with fast delivery and reliable support.
Further Information
Tumour antigen 19-9, abbreviated CA 19-9, is a glycoprotein used as a tumour marker in oncology. It has a molecular weight of 10 kDa and is derived from the Lewis-a blood group determinant.
You may also be interested in
The determination of PIC content has facilitated the early diagnosis of thrombotic diseases, the formulation of treatment plans and the monitoring of prognosis effect. Tests: 60. Test volume: 50 μL. Sample type: Plasma
Delivery / installation will take place shortly after order confirmation
AMH is a good marker for evaluating ovarian function and assisting in the diagnosis of ovarian related diseases. Tests: 60. Test volume: 50 μL. Test material: Serum, Plasma, Whole blood.
Delivery / installation will take place shortly after order confirmation